F-Prime Capital is an early-stage venture capital fund focused on biotech and health tech, with investments ranging from $500,000 to $10 million. Backed by Fidelity Investments, founded in 1946, F-Prime has a history of supporting entrepreneurs. They have funded companies like ARTBIO, Genomics, and Tenpoint Therapeutics. Operating in the US and Europe, with a sister fund, Eight Roads, working globally, F-Prime provides valuable insights and support without the pressure of outside investors.
